APOLLO Trial Transcatheter Mitral Valve Replacement with the Medtronic Intrepid TMVR System in patients with severe symptomatic mitral regurgitation.
APOLLO Trial for patients with Mitral regurgitation
Sponsor: Medtronic, Inc.
Enrolling: Male and Female Patients
IRB Number: AAAR5579
U.S. Govt. ID: NCT03242642
Contact: Kate Dalton: 347-514-3366 / keb2114@cumc.columbia.edu
Additional Study Information: This is designed for patients with severe, symptomatic mitral regurgitation who are not candidates for conventional mitral repair.
Investigator
Susheel Kodali, MD
Do You Qualify?
Do you have mitral regurgitation? Yes No
Do you have heart palpitations? Yes No
Do you have shortness of breath? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder



Cancel
For more information, please contact:
Kate Dalton
keb2114@cumc.columbia.edu
347-514-3366
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE